Data science teams in the life sciences industry are experiencing a significant change that will transform how clinical data is analyzed, opening the door to new possibilities for innovation. The transition isn’t happening overnight, but such incremental approaches are necessary to ensure success in such a highly regulated environment.
For decades, SAS was “it” in life sciences. If you wanted to be a data scientist in the industry, you had to know SAS. However, recently there has been a move
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Medidata Platform Enhances Clinical Trial Efficiency for Bristol Myers Squibb
What You Should Know:
- Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has announced an extended and expanded partnership with Bristol Myers Squibb (BMS).
- This collaboration aims to enhance clinical research processes, improve patient outcomes, and foster advancements in personalized healthcare.
Medidata and Bristol Myers Squibb Strengthen Partnership to Advance Clinical Research and Personalized Healthcare
As
Read More
Pepticom Secures $6.6M to Advance AI-Powered Peptide Drug Discovery
What You Should Know:
- Pepticom, an innovator in AI-driven peptide-based therapeutics secures $6.6M in a Series A1 funding round led by Japan Israel High Tech Ventures 2 LP, with strong support from existing investors.
- The new funding will accelerate the development of Pepticom's oral IL-17 inhibitor program, focusing on creating improved treatments for autoimmune diseases like psoriasis and psoriatic arthritis.
Revolutionizing Autoimmune Disease Treatment
Pepticom is
Read More
ActiGraph Acquires Biofourmis Life Science Business
What You Should Know:
- ActiGraph, a global leader in wearable digital health technology, announced the acquisition of Biofourmis Connect, a division of Biofourmis specializing in AI-powered digital trial platforms for the life science industry. Financial terms of the acquisition were not disclosed.
- The acquisition combines ActiGraph's expertise in wearable technology with Biofourmis Connect's advanced analytics capabilities, creating a comprehensive and unified solution for
Read More
M&A: Predictive Oncology to be Acquired by Renovaro
What You Should Know:
- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced its upcoming acquisition by Renovaro, Inc. (NASDAQ: RENB) in a strategic move aimed at accelerating innovation and improving cancer treatment outcomes.
- The merger brings together two companies with a shared commitment to leveraging artificial intelligence and machine learning to transform cancer care.
Synergistic Strengths and Shared Vision
Both Predictive
Read More
Funding Challenges for Innovation in MedTech in 2025
In the MedTech sector, small and medium-sized organizations are the primary drivers of innovation, developing new technologies for diagnosing, monitoring, and treating various conditions. Despite their potential to transform patient care and enhance efficiency in healthcare environments, these companies face significant funding challenges. The high costs of development, complex regulatory pathways, and intense market competition create substantial barriers to attracting investors.
MedTech
Read More
How Digital Twins Open The Door for Next-Gen Clinical Trials
Clinical trials have been the cornerstone of medical innovation for centuries, but as the effort continues to improve patient care and speed the development of new treatments and medicines, sticking with the same old trial processes is no longer an option.
Innovative technologies like digital twins and generative AI are transforming the healthcare landscape and expanding what’s possible for the future of medicine with next-gen clinical trials.
Beyond benefits associated with
Read More
Personalis Secures $50M from Merck, Extends Collaboration with Moderna
What You Should Know:
- Personalis, Inc. (NASDAQ: PSNL) today announced agreements with long-time collaborators Merck and Moderna that accelerate the advancement of the company’s business strategy.
- The company has received a $50M investment from Merck, known as MSD outside the United States and Canada, and separately has signed a multi-year extension with Moderna to utilize Personalis’ ImmunoID NeXT Platform® and technology for V940/mRNA-4157, an investigational
Read More
eClinical Solutions & Snowflake Integrate Clinical Data Management
What You Should Know:
- eClinical Solutions LLC, a global leader in digital clinical software and services, has announced a strategic collaboration with Snowflake, the AI Data Cloud company.
- This partnership establishes a bidirectional integration designed to address the growing challenges in managing clinical data while enabling life sciences organizations to unlock greater value through a modern clinical data architecture.
eClinical Solutions Partners with Snowflake to Enhance
Read More
BrightInsight, Sanofi to Build Drug Companion Apps for its Major Specialty Therapies
What You Should Know:
- BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that began in 2022 when Sanofi selected the BrightInsight Platform to accelerate the development of a SaMD for one of its specialty care medicines.
- The goal of the collaboration aims to accelerate Sanofi's drug development timeline and
Read More
